Schizophrenia Bulletin · 2021 · 102 citations · 25 references
MedicineHealth SciencesPsychiatryClinical EpidemiologyEpidemiologic MethodsEpidemiologyComorbidityMental HealthMorbidity AnalysisPsychiatric EpidemiologySchizophrenia Spectrum DisordersSocioeconomic Determinants Of HealthChronic Obstructive Pulmonary Disease EpidemiologyCurrent Marital StatusHousehold Socioeconomic StatusLogistic RegressionMarital Status ClassificationPatient Demographic VariablesSchizophrenia ComorbiditySocioeconomic Inequalities In Morbidity
OBJECTIVE: Individuals with schizophrenia may be at an increased risk for COVID-19 morbidity due to the disease characteristics. In this study, we aimed to explore the odds of significant COVID-19 morbidity and mortality among schizophrenia patients while controlling for potential sociodemographic and medical confounders. METHODS: Schizophrenia patients and age-and-sex matched controls (total n = 51 078) were assessed for frequency of COVID-19 positivity, hospitalizations, and mortality. The odds for COVID-19-associated hospitalization and mortality were calculated using logistic regression models, while controlling for age, sex, marital status, sector, socioeconomic status, diabetes, ischemic heart disease, hypertension, hyperlipidemia, obesity, smoking, and chronic obstructive pulmonary disease. RESULTS: Individuals with schizophrenia were less likely to test positive for COVID-19; however, they were twice as likely to be hospitalized for COVID-19 (OR 2.15 95% CI 1.63-2.82, P < .0001), even after controlling for sociodemographic and clinical risk factors (OR 1.88 95% CI 1.39-2.55, P < .0001). Furthermore, they were 3 times more likely to experience COVID-19 mortality (OR 3.27 95% CI 1.39-7.68, P < .0001), compared to controls. CONCLUSIONS: We found evidence of associations between schizophrenia and increased COVID-19 morbidity and mortality compared to controls regardless of sociodemographic and medical factors. As these patients present with a combination of potential risk factors for mortality, efforts should be made to minimize the effects of the pandemic on this vulnerable population.
25
Andrew Clark, Mark Jit, Charlotte Warren‐Gash et al. · The Lancet Global Health · 2020 · 1.2K citations · Full text
Veterinary Medicine, Infectious Diseases, Population Health Sciences +17
Premature Mortality Among Adults With Schizophrenia in the United States
Mark Olfson, Tobias Gerhard, Cecilia Huang et al. · JAMA Psychiatry · 2015 · 1.1K citations · Full text
Dan Cohen, Julio Bobes, Marcelo Cetkovich et al. · World Psychiatry · 2011 · 864 citations · Full text
Medicine, Health Policy, Psychiatry +16